Flavia Borellini
CIK: 0001867426
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Borellini Flavia
Borellini Flavia (SEC CIK 0001867426) files insider reports with the SEC as Director of PLIANT THERAPEUTICS, INC. (PLRX) and Director of Revolution Medicines, Inc. (RVMD).
Signal8 holds 4 ownership filings by Borellini Flavia (1 Form 3, 3 Form 4), filed between Jun 30, 2025 and Jul 13, 2026. Those filings report 3 transactions, from Jun 26, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Borellini Flavia's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Borellini Flavia
Other insiders filing for PLIANT THERAPEUTICS, INC. (PLRX)
- Raben David, Chief Medical Officer
- Iannone Robert, Director
- CROWELL GAYLE A, Director
- MCCOURT Thomas A, Director
- Krognes Steve E., Director
- Curnutte John T, Director